Copyright (c) 2026 Futuristic Publications

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Analytical method development and validation for Simultaneous estimation of abacavir and lamivudine in pharmaceutical dosage form: A comprehensive re-view of existing analytical techniques
Corresponding Author(s) : P. Vivek Sagar
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 14 No. 4 (2026): 2026 Volume 14-Issue 4
Abstract
The combination of Abacavir (ABC) and Lamivudine (3TC) represents a widely prescribed nucleoside reverse transcriptase inhibitor (NRTI) backbone in highly active antiretroviral therapy (HAART) for the management of Human Immunodeficiency Virus (HIV) infection. Accurate, precise, and reliable analytical methods are indispensable for quality control, pharmacokinetic investigations, bioequivalence studies, and routine pharmaceutical analysis of these antiretroviral agents. This review comprehensively surveys and critically evaluates the analytical techniques published to date for the individual and combined determination of Abacavir and Lamivudine in pharmaceutical formulations and biological matrices. Techniques reviewed include ultraviolet visible (UV) spectrophotometry, High Performance Liquid Chromatography (HPLC), Liquid Chromatography coupled with Mass Spectrometry (LC MS/MS), Gas Chromatography (GC), and High Performance Thin Layer Chromatography (HPTLC). For each technique, the published methodologies are critically assessed with respect to their chromatographic or spectroscopic conditions, linearity, limits of detection (LOD), limits of quantification (LOQ), precision, accuracy, and regulatory compliance with International Council for Harmonisation (ICH) guidelines. A critical observation emerging from this survey is that, to date, no validated simultaneous analytical method has been specifically developed and reported for the binary combination of Abacavir and Lamivudine as co formulated in a fixed dose combination (FDC) pharmaceutical dosage form. This gap in the literature underscores the necessity and scientific relevance of developing a novel, robust, and validated analytical method for the simultaneous estimation of these two drugs, as proposed in the current work.